The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
The volume and pace of cancer research, from preclinical studies to clinical trials and FDA approvals, can make it challenging to stay informed. This section highlights the latest developments and translates complex scientific concepts into clear, accessible insights for both healthcare professionals and the broader public.
Dr. Michael Snyder on Advances in Genomic Medicine: Multi-Omics Approaches to Cancer Research and AI Applications in Precision Health
By The Cancer News Team
Dr. Michael Snyder of Stanford Medicine discusses how multi-omics research and artificial intelligence are reshaping cancer biology, early detection, and precision health, using familial adenomatous polyposis as a model.
Dr. Michael Snyder on Advances in Genomic Medicine: Multi-Omics Approaches to Cancer Research and AI Applications in Precision Health
By The Cancer News Team
Dr. Michael Snyder of Stanford Medicine discusses how multi-omics research and artificial intelligence are reshaping cancer biology, early detection, and precision health, using familial adenomatous polyposis as a model.
Dr. Michael Snyder on Advances in Genomic Medicine: Multi-Omics Approaches to Cancer Research and AI Applications in Precision Health
By The Cancer News Team
Dr. Michael Snyder of Stanford Medicine discusses how multi-omics research and artificial intelligence are reshaping cancer biology, early detection, and precision health, using familial adenomatous polyposis as a model.
Stanford Medicine Clinicians Highlight How Radiologists, Surgeons, and Pathologists Can Advance Precision Oncology Treatment
By The Cancer News Team
Stanford Medicine experts discuss how radiology, surgery, and pathology inform precision oncology, highlighting imaging phenotypes, treatment response assessment, and opportunities for surgical de-escalation in breast cancer care.
Stanford Medicine Clinicians Highlight How Radiologists, Surgeons, and Pathologists Can Advance Precision Oncology Treatment
By The Cancer News Team
Stanford Medicine experts discuss how radiology, surgery, and pathology inform precision oncology, highlighting imaging phenotypes, treatment response assessment, and opportunities for surgical de-escalation in breast cancer care.
Stanford Medicine Clinicians Highlight How Radiologists, Surgeons, and Pathologists Can Advance Precision Oncology Treatment
By The Cancer News Team
Stanford Medicine experts discuss how radiology, surgery, and pathology inform precision oncology, highlighting imaging phenotypes, treatment response assessment, and opportunities for surgical de-escalation in breast cancer care.
Dr. Stephen B. Gruber on Germline Genetic Testing in Cancer Treatment Drag
By The Cancer News Team
Dr. Stephen B. Gruber discusses how germline genetic testing shapes cancer therapy selection, reveals gaps in current guidelines, and presents INSPIRE study data supporting universal access to comprehensive genetic testing.
Dr. Stephen B. Gruber on Germline Genetic Testing in Cancer Treatment Drag
By The Cancer News Team
Dr. Stephen B. Gruber discusses how germline genetic testing shapes cancer therapy selection, reveals gaps in current guidelines, and presents INSPIRE study data supporting universal access to comprehensive genetic testing.
Dr. Stephen B. Gruber on Germline Genetic Testing in Cancer Treatment Drag
By The Cancer News Team
Dr. Stephen B. Gruber discusses how germline genetic testing shapes cancer therapy selection, reveals gaps in current guidelines, and presents INSPIRE study data supporting universal access to comprehensive genetic testing.
Liquid Biopsy in Oncology: What Clinicians Are Actually Saying
By The Cancer News Team
A multidisciplinary panel of oncology experts discusses real-world use of liquid biopsy, comparing it with tissue biopsy and exploring clonal hematopoiesis, tumor-informed assays, minimal residual disease testing, and circulating tumor DNA.
Liquid Biopsy in Oncology: What Clinicians Are Actually Saying
By The Cancer News Team
A multidisciplinary panel of oncology experts discusses real-world use of liquid biopsy, comparing it with tissue biopsy and exploring clonal hematopoiesis, tumor-informed assays, minimal residual disease testing, and circulating tumor DNA.
Liquid Biopsy in Oncology: What Clinicians Are Actually Saying
By The Cancer News Team
A multidisciplinary panel of oncology experts discusses real-world use of liquid biopsy, comparing it with tissue biopsy and exploring clonal hematopoiesis, tumor-informed assays, minimal residual disease testing, and circulating tumor DNA.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh; Dr. Ibrahim Sahin
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh; Dr. Ibrahim Sahin
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside
By Dr. Meghana Singh; Dr. Ibrahim Sahin
Key clinical trial highlights from ASCO GI 2026, covering practice-changing data in gastric, colorectal, pancreatic, and liver cancers, including HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER.
Dr. Matthew H. Schwede’s Insights on Advances in Cellular Therapy
By The Cancer News Team
An expert overview of key advances in cellular therapy presented by Dr. Matthew H. Schwede at the Best of Hematology & Breast Cancer 2026 conference, focusing on CAR T innovation, rapid manufacturing, in vivo approaches, and emerging treatment strategies.
Dr. Matthew H. Schwede’s Insights on Advances in Cellular Therapy
By The Cancer News Team
An expert overview of key advances in cellular therapy presented by Dr. Matthew H. Schwede at the Best of Hematology & Breast Cancer 2026 conference, focusing on CAR T innovation, rapid manufacturing, in vivo approaches, and emerging treatment strategies.
Dr. Matthew H. Schwede’s Insights on Advances in Cellular Therapy
By The Cancer News Team
An expert overview of key advances in cellular therapy presented by Dr. Matthew H. Schwede at the Best of Hematology & Breast Cancer 2026 conference, focusing on CAR T innovation, rapid manufacturing, in vivo approaches, and emerging treatment strategies.
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
What Are Doctors Saying About Cancer Prevention? Insights from Leading Oncologists
By The Cancer News Team
Leading oncologists discuss evidence-based cancer prevention strategies, treatment-related weight gain, and major gaps in survivorship care, based on insights shared at a major oncology conference.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia
By The Cancer News Team
Summary of Dr. Bart L. Scott’s presentation on first-line treatment strategies for newly diagnosed acute myeloid leukemia, highlighting azacitidine–venetoclax, the Paradigm trial, and patient-centered decision-making.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
How Medical Oncologists Select Targeted Therapies for Breast Cancer ESR1 and Pancreatic MTAP Mutations
By The Cancer News Team
Expert tumor board discussion from the Precision Oncology Summit on ESR1-mutant breast cancer and MTAP-deleted pancreatic cancer, highlighting real-world cases, oral SERDs, PRMT5 inhibitors, and biomarker-driven treatment decisions.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Dr. Akriti Jain
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Dr. Akriti Jain
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.
New Study Offers Hope for Better Treatment Strategies: Understanding Blast Phase Chronic Myeloid Leukemia
By Dr. Akriti Jain
A leukemia specialist discusses new insights from a multicenter U.S. study on blast phase chronic myeloid leukemia, highlighting treatment patterns, outcomes, and the critical role of TKIs and transplantation.